Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-05-13

Clinical Trial Update: Immunogenetic Factors of Coronary Heart Disease

View source ↗

Summary

This completed NHLBI-supported study investigates how immunogenetic factors influence the risk of coronary heart disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Coronary Disease | Status: COMPLETED